Association of mitochondrial deoxyribonucleic acid mutation with polymorphism in CYP2E1 gene in oral carcinogenesis

Journal of Oral Biology and Craniofacial Research

Volumn 2, Issue 1, 2012, Pages 4-9

  Pandey, Rahul ^a   Mehrotra, Divya ^a   Catapano, Carlo ^b   Choubey, Vimal ^a   Sarin, Rajiv ^c   Mahdi, Abbas Ali ^a   Singh, Stuti ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b INSTITUTE OF ONCOLOGY RESEARCH   (Switzerland)

^c ACTREC   (India)

Author keywords

CYP2E1; DNA; Mitochondria; Oral cancer

Indexed keywords

EID: 84894886831     PISSN: 22124268     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2212-4268(12)60003-7     Document Type: Article

References (24)

1. Stewart BW, Kleihues P World Cancer Report 2003, 1-351. WHO International Agency for Research on Cancer, Lyon.
2. Brennan P, Boffetta P Mechanistic considerations in the molecular epidemiology of head and neck cancer. IARC Sci Publ 2004, 157:393-414.
3. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K Genetic polymorphisms of CYP gene, alone or in combination as a risk modifier of tobacco related cancers. Cancer Epidemiol Biomarker Prev 2000, 9:3-28.
4. Danko IM, Chaschin NA Association of CYP2E1 gene polymorphism with predisposition to cancer development. Exp Oncol 2005, 27:248-256.
5. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Scott EM Facile detection of mitochondrial DNA mutations in tumours and bodily fluids. Science 2000, 287:2017-2019.
6. Copeland WC, Wachsman JT, Johnson FM, Penta JS Mitochondrial DNA alterations in cancer. Cancer Invest 2002, 20:557-569.
7. Lee HC, Lu CY, Fahn HJ, Wei YH Aging- and smoking-associated alteration in the relative content of mitochondrial DNA in human lung. FEBS Lett 1998, 441:292-296.
8. Kim MM, Glazer CA, Mambo E, Chatterjee A, Zhao M, Sidransky D Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO. Oral Oncol 2006, 42:201-207.
9. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P Elucidation of CYP2E1 5' regultory Rsal/PstI allelic variants and their role in risk for oral cancer. Oral Oncol 2001, 37:437-445.
10. Vidal F, Lorenzo A, Auguet T, et al. Genetic polymorphisms of ADH2, ADH3, CYP4502E1Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease. J Hepatol 2004, 41:744-750.
11. Wong LJC, Liang MH, Kwon H Comprehensive scanning of the whole mitochondrial genome for mutations. Clin Chem 2002, 48:1901-1912.
12. Shiu MN, Chan TH, Chang SH, Hahn LJ Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 2000, 82:1871-1874.
13. Guengerich FP, Kim DH, Iwasaki M Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991, 4:168-179.
14. Hayashi S, Watanabe J, Kawajiri K Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991, 110:559-565.
15. Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Watanabe M Association between restriction fragment length polymorphism of the human cytochrome P45011E1 gene and susceptibility to lung cancer. Jpn J Cancer Res 1991, 82:254-256.
16. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997, 6:901-905.
17. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol 2001, 37:437-445.
18. Uematsu F, Ikawa S, Kikuchi S, et al. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics 1994, 4:58-63.
19. Matthias C, Bockmuhl U, Jahnke V, et al. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 1998, 8:91-100.
20. Sikdar N, Mahmud SK, Paul RR, Roy B Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 2003, 195:33-42.
21. Hildesheim A, Anderson LM, Chen CJ, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997, 89:1207-1212.
22. Sugimura T, Kumimoto H, Tohnai I, et al. Gene-environment interaction involved in oral carcinogenesis: Molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 2006, 35:11-18.
23. Soya SS, Vinod T, Reddy KS, Gopalakrishnan S, Adithan C CYP2E1 polymorphisms and gene-environment interactions in the risk of upper aerodigestive tract cancers among Indians. Pharmacogenomics 2008, 9:551-560.
24. Garte S, Gaspari L, Alexandrie AK Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001, 10:1239-1248.